CAREMAX INC(CMAXQ.US)

Company Encyclopedia

CAREMAX INC

CMAXQ.US

395.20 B

CMAXQ.USMarket value -Rank by Market Cap -/-

Financial Score

23/01/2026 Update

Health Care ServicesIndustry

Industry Ranking81/82

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreE
- ROE-328.42%E
- Profit Margin-99.78%E
- Gross Margin1.47%E
Growth ScoreD
- Revenue YoY9.06%B
- Net Profit YoY-520.94%E
- Total Assets YoY-60.55%E
- Net Assets YoY-123.66%E
Cash ScoreC
- Cash Flow Margin-100.22%D
- OCF YoY9.06%B
Operating ScoreA
- Turnover0.98A
Debt ScoreE
- Gearing Ratio132.54%E

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
No Data

News

High-dose biologic delivery to become industry standard

Phillips Medisize's CEO, Tony Bedford, predicts that high-dose biologics will become the industry standard as the pharmaceutical sector shifts towards subcutaneous (SC) drug delivery. This trend is driven by the need for patient-centric therapies that enhance comfort and reduce treatment time. With eight of the top ten selling drugs now in SC format, the move away from intravenous (IV) formulations is evident. High-dose SC administration allows for outpatient treatment, alleviating pressure on healthcare systems, although challenges remain regarding insurance coverage for these therapies.

Pharmaceutical Technology·5 Hours ago

10:50 ET Medical Image Management Market Surges to USD 10.2 Billion by 2033, Propelled by 9.8% CAGR - Verified Market Reports®

The Global Medical Image Management Market is projected to grow from USD 4.5 billion in 2024 to USD 10.2 billion by 2033, with a CAGR of 9.8%. Growth is driven by increasing imaging volumes, digital transformation in healthcare, and demand for interoperability. Key factors include telehealth expansion, EMR integration, and AI-enabled workflow optimization. North America leads in revenue, while Asia-Pacific shows the fastest growth. The market is evolving towards unified enterprise imaging platforms and cloud-based models, enhancing efficiency and supporting advanced diagnostics.

prnewswire·Yesterday at 23:52

US set to quit World Health Organization

The U.S. is set to officially exit the World Health Organization (WHO) on Thursday, following President Trump's executive order. This departure, which violates U.S. law regarding unpaid fees, is expected to negatively impact both U.S. and global health. Experts, including WHO's Director General, have urged reconsideration, highlighting the potential risks of weakened health systems. The U.S. has historically contributed 18% of WHO's funding, and its exit may lead to significant budget cuts and staff reductions within the organization. Bill Gates expressed skepticism about a quick return to the WHO by the U.S.

Yahoo Finance·Yesterday at 23:12

Worldwide Clinical Trials to acquire Catalyst

Worldwide Clinical Trials has agreed to acquire Catalyst Clinical Research, an oncology CRO, to enhance its capabilities in oncology and expand its global reach. The integration will combine Catalyst’s solutions with Worldwide’s portfolio, improving service offerings and operational efficiency. Catalyst's chairman will join Worldwide's board, and its CEO will be part of Worldwide's leadership team. The acquisition is pending regulatory approvals and is expected to conclude in Q1 2026.

WorldPharmaceuticals·Yesterday at 18:21

Should you buy CVS Health stock before Feb. 10?

The diversified healthcare company reports earnings next month.

MSN·01/22/2026 06:12